Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.5
1.23%
40%
—
-73.69%
40%
—
5 Years
Score3.5
Net Growth1.23%
Net Trend40%
Net Income Consistency—
Rev Growth-73.69%
Rev Trend40%
Revenue Consistency—
CytomX Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 68M to $ 76M and net income went from -$ 64M to -$ 17M. Revenue increased in 2 of those 5 years; net income in 2.
Across CytomX Therapeutics Inc's full reported history, from 2015 to 2025, revenue grew from $ 7M to $ 76M and net income went from -$ 35M to -$ 17M. Revenue increased in 55% of the years measured; net income in 36%.
CytomX Therapeutics Inc currently holds a 5-year HDB Score of 3.5 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.49 | — |
1 Year2025-08-12 | $ 1.86 | 87.63% |
5 Years2021-08-12 | $ 4.95 | -29.49% |
10 Years2016-08-12 | $ 11.15 | -68.70% |
All Time2015-10-08 | $ 12.90 | -72.95% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2015-10-08 |
|---|---|---|---|---|---|
| Price | $ 3.49 | $ 1.86 | $ 4.95 | $ 11.15 | $ 12.90 |
| Return | — | 87.63% | -29.49% | -68.70% | -72.95% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 18M | -$ 79M | $ 330M |
| 2025 | $ 76M | -$ 17M | $ 137M |
| 2024 | $ 138M | $ 31M | $ 100M |
| 2023 | $ 101M | -$ 569K | $ 174M |
| 2022 | $ 53M | -$ 97M | $ 193M |
| 2021 | $ 69M | -$ 80M | $ 305M |
| 2020 | $ 68M | -$ 64M | $ 316M |
| 2019 | $ 57M | -$ 102M | $ 296M |
| 2018 | $ 59M | -$ 84M | $ 436M |
| 2017 | $ 71M | -$ 43M | $ 374M |
| 2016 | $ 15M | -$ 58M | $ 181M |
| IPO2015 | $ 7M | -$ 35M | $ 186M |
Explore beyond CTMX
You're looking at CytomX Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
